Clinical Trials Logo

Filter by:
NCT ID: NCT05442398 Active, not recruiting - Clinical trials for Celiac Disease in Children

Celiac Disease and Diabetes Mellitus

Start date: July 1, 2022
Phase:
Study type: Observational [Patient Registry]

The aim of the present study is to detect Celiac Disease among suspected patients with Type 1 Diabetes Mellitus who admitted to Assiut University Children's Hospital during one year duration

NCT ID: NCT05442333 Active, not recruiting - Clinical trials for Resectable Soft Tissue Sarcoma

Adjuvant Versus Neo-adjuvant Radiotherapy in Patients With Resectable Soft Tissue Sarcoma in Extremities : Wound Complications

Start date: September 1, 2021
Phase: N/A
Study type: Interventional

Extremity soft tissue sarcomas (ESTS)s are rare mesenchymal cancers that considered a challenge for orthopaedic surgeons. Soft tissue sarcomas (STS) comprise less than 1% of malignant cancers, commonly occur in the proximal extremities and trunk. Limb-sparing surgery mostly are targeted in most of the patients, so adjuvant or neoadjuvant radiotherapy is usually added. Preoperative radiotherapy (neoadjuvant) or postoperative radiotherapy (adjuvant) offers local control and survival rates, but the local complications are controversial. However, different retrospective studies had shown that preoperative radiotherapy cause higher wound complication rate, while both preoperative and postoperative radiotherapy had the same results regarding local recurrence

NCT ID: NCT05439486 Active, not recruiting - Clinical trials for Erectile Dysfunction

New Treatment in Erectile Dysfunction Patients.

Start date: January 29, 2022
Phase: N/A
Study type: Interventional

Erectile dysfunction patients who are non responder to sildenafil will be treated with hyperbaric oxygen therapy with 100% concentration and at 2 ATM for 30 consecutive sessions each one 90 minutes and then will be reassessed.

NCT ID: NCT05437744 Active, not recruiting - Tooth Socket Clinical Trials

Immediately Placed Implant Sealed With Platelets Rich Fibrin Versus Cyanoacrylate Glue

Start date: December 12, 2021
Phase: N/A
Study type: Interventional

The health of peri-implant soft tissues is one of the most important aspects necessary for the long-term survival of dental implants. The importance of the peri-implant mucosal region lies in the need to establish a tight seal that isolates the implant and the bone from the oral environment. Study objective is to clinically compare the soft tissue healing, height, and thickness over immediate implants placed in type I sockets sealed by PRF to those sealed by a Cyanoacrylate glue.

NCT ID: NCT05437731 Active, not recruiting - Orbital Deformity Clinical Trials

Titanium Mesh Coated With Natural Hydroxyapatite Nanocrystals in Orbital Reconstruction

Start date: March 1, 2022
Phase: N/A
Study type: Interventional

Reconstruction of maxillofacial continuity defects has always been a challenging task for scientists and surgeons over the years. The main goal of the reconstruction of the maxillofacial region is to restore facial form, function, and full rehabilitation of occlusion and articulation. A refinement in surgical technique and methods of reconstruction has improved patients' quality of life. Aim of this study: Evaluation of titanium mesh coated with natural hydroxyapatite in orbital reconstruction.

NCT ID: NCT05437432 Active, not recruiting - Dental Caries Clinical Trials

Esthetic Evaluation of Onlay Restorations Constructed From Vita Ambria Glass Ceramics

Start date: March 1, 2022
Phase: N/A
Study type: Interventional

There is limited data available on VITA AMBRIA glass ceramic , so this study is conducted to investigate the esthetic parameters of this new glass press system.

NCT ID: NCT05437172 Active, not recruiting - Alveolar Bone Loss Clinical Trials

Evaluation of Autogenous Demineralized Dentin Graft for Ridge Preservation With and Without Injectable Platelet Rich Fibrin

Start date: June 30, 2022
Phase: N/A
Study type: Interventional

Ridge preservation should be considered whenever possible after tooth extraction. Whether implant placement would be performed or for aesthetic consideration at pontic sites when conventional bridge is planned. Ridge preservation aims to maximize the bone formation accompanied with good soft tissue architecture to facilitate implant and prosthetic replacement restoring function, phonetics and aesthetics. the Aim of the study is To evaluate the bucco-lingual ridge width clinically and radiographically, height of buccal and lingual ridges of the socket after application of injectable platelet rich fibrin and autogenous dentin graft.

NCT ID: NCT05433051 Active, not recruiting - Dental Intrusion Clinical Trials

A Comparison of Two Protocol for Maxillary Molar Intrusion Buccal Miniscrew and TPA Versus Vertical Holding Appliance

Start date: April 10, 2022
Phase: N/A
Study type: Interventional

this study is to compare the dental and skeletal changes caused by the intrusion of maxillary first molars buccal miniscrew and TPA versus vertical holding appliance using lateral cephalometry.

NCT ID: NCT05433038 Active, not recruiting - Posterior Crossbite Clinical Trials

Effects of Skeletally Anchored Maxillary Expander Via Two Approaches of Microosteoperforations

Start date: May 20, 2022
Phase: N/A
Study type: Interventional

study will be directed to evaluate two approaches of microosteoperforations during skeletally anchored maxillary expansion

NCT ID: NCT05432531 Active, not recruiting - Lupus Nephritis Clinical Trials

Efficiency of Use of Baracetinib in Treatment of Lupus Nephritis

Start date: June 1, 2022
Phase: Phase 3
Study type: Interventional

Patients with systemic lupus erythematosus have substantial unmet medical need. Baricitinib is an oral selective Janus kinase (JAK)1 and JAK2 inhibitor that we hypothesised might have therapeutic benefit in patients with systemic lupus erythematosus and had a diagnosis of systemic lupus erythematosus, and had active renal disease as defined by Systemic Lupus Erythematosus Disease Activity Index-2000 (SLEDAI-2K). Efficacy and safety analyses included all patients who received at least one dose of study drug.